Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemetrexed Monotherapy as Salvage Treatment in Metastatic Colorectal Cancer
KCT0003517Phase 2Completed
- Sponsor
- Dong-A ST
- Start
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pemetrexed in metastatic colon cancer (mCRC), sponsored by Dong-A ST. Started Jun 2016; status: completed.
02
Drugs
pemetrexed
03
Conditions
metastatic colon cancer (mCRC)
Beyond the preview
Go deeper on KCT0003517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0003517.